#cancerresearch @jama_current
NACT (#neoadjuvantchemotherapy ) Use Appears to be Increasing in Less Common #Epithelial #ovariancancer
•NACT may be associated with poor survival outcomes in low-grade serous carcinomas.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/280618
#cancerresearch #neoadjuvantchemotherapy #epithelial #ovariancancer